Antiphospholipid syndrome

Last updated: Monday, 26, July, 2010
Key InformationAppropriate Tests

The syndrome is characterised by arterial and venous thrombosis, an increased risk of miscarriage and fetal death and intra-uterine growth retardation.

Diagnosis is based on clinical findings in the presence of a significant titre of cardiolipin antibodies (titre >20 GPL units) or lupus inhibitor or beta-2-glycoprotein 1 antibody.